SEC Form 4 · accession 0000904454-16-000900
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Blair
Director
Period of report
Jan 27, 2016
Accepted (ET)
Jan 29, 2016 · 12:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.14 | Jan 27, 2016 | A | 19,428 | A | — | Jan 27, 2026 | Common Stock | 19,428 | 19,428 | D |
Explanation of responses
- F1The option vests monthly over three years with a vesting commencement date of 01/27/2016.